Billy Wynne

GAO Report Finds HHS Lacks Coordinated National Strategy for Pandemic Diagnostic Testing

By Billy Wynne / June 4, 2025

GAO Report Finds HHS Lacks Coordinated National Strategy for Pandemic Diagnostic Testing The Government Accountability Office (GAO) released a report demonstrating findings that the Department of Health and Human Services (HHS) lacks a coordinated, national approach for diagnostic testing related to infectious diseases with pandemic potential. HHS leads federal efforts through agencies such as the…

Read More

OIG Identifies $50 Billion in Potential Cost Savings Through Payment Recovery and Program Improvements

By Billy Wynne / May 23, 2025

OIG Identifies $50 Billion in Potential Cost Savings Through Payment Recovery and Program Improvements The Department of Health and Human Services Office of Inspector General (HHS OIG) released a report identifying $50 billion in potential cost savings through payment recovery and program improvements based on HHS-OIG work. There are 35 OIG reports identified for potential cost…

Read More

House Votes to Approve Budget Reconciliation Bill, 215-214

By Billy Wynne / May 22, 2025

House Votes to Approve Budget Reconciliation Bill, 215-214 The House of Representatives approved their budget reconciliation bill by a vote of 215-214, with Reps. Thomas Massie (R-KY) and Warren Davidson (R-OH) as the only Republicans to vote against the bill. Earlier in the day, the bill cleared the last hurdle to advancing to the House…

Read More

Subcommittee on Commerce, Manufacturing, and Trade Weighs 10-Year Ban on State AI Laws Amid Debate Over Innovation and Consumer Protection

By Billy Wynne / May 22, 2025

Subcommittee on Commerce, Manufacturing, and Trade Weighs 10-Year Ban on State AI Laws Amid Debate Over Innovation and Consumer Protection The House Energy and Commerce Subcommittee on Commerce, Manufacturing, and Trade held a hearing on AI regulation and U.S. competitiveness. The hearing focused heavily on a contentious proposal for a 10-year federal moratorium on state-level…

Read More

Dr. Makary Reveals 5.5% FDA Budget Cut at Hearing; Senators Raise Alarms on Recent RIFs and Reported Delays at the Agency

By Billy Wynne / May 22, 2025

Dr. Makary Reveals 5.5% FDA Budget Cut at Hearing; Senators Raise Alarms on Recent RIFs and Reported Delays at the Agency The Senate Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies held a hearing with Commissioner of the Food and Drug Administration (FDA), Dr. Martin Makary, to review the Fiscal…

Read More

FTC Finalizes Order Against Welsh Carson for Antitrust Violations in Texas Anesthesiology Market

By Billy Wynne / May 21, 2025

FTC Finalizes Order Against Welsh Carson for Antitrust Violations in Texas Anesthesiology Market On May 20, 2025, the Federal Trade Commission (FTC) finalized a consent order with private equity firm Welsh, Carson, Anderson & Stowe (Welsh Carson) and its affiliates, resolving allegations that the firm orchestrated a years-long consolidation strategy in Texas’s anesthesiology market through…

Read More

RFK Jr. Faces Continued Bipartisan Pushback on HHS Budget; Alarms Raised Over Cuts and Program Eliminations

By Billy Wynne / May 20, 2025

RFK Jr. Faces Continued Bipartisan Pushback on HHS Budget; Alarms Raised Over Cuts and Program Eliminations The Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies held a hearing to review the Fiscal Year (FY) 2026 budget for the Department of Health and Human Services (HHS) with Secretary Robert F. Kennedy…

Read More

New Framework for COVID-19 Vaccination Released; Vaccination Recommended for Individuals with Risk Factors and Adults Over the Age of 64

By Billy Wynne / May 20, 2025

New Framework for COVID-19 Vaccination Released; Vaccination Recommended for Individuals with Risk Factors and Adults Over the Age of 64 Food and Drug Administration (FDA) Commissioner Marty Makary and Director of the Center for Biologics Evaluation and Research (CBER) released a new framework for COVID-19 vaccination, in which the agency will recommend vaccination for adults…

Read More

Most-Favored-Nation Pricing Targets Released; MFN Rulemaking to Occur if Commitments are not Made

By Billy Wynne / May 20, 2025

Most-Favored-Nation Pricing Targets Released; MFN Rulemaking to Occur if Commitments are not Made Pursuant to President Trump’s Executive Order (EO) on Delivering Most-Favored-Nation (MFN) Prescription Drug Pricing to American Patients, the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) announced that the agencies have identified specific MFN…

Read More

FDA RFI on Infant Formula Nutrient Review

By Billy Wynne / May 16, 2025

FDA RFI on Infant Formula Nutrient Review The Food and Drug Administration (FDA) issued a request for information (RFI) to begin its process of reviewing nutrition requirements in infant formulas. FDA regularly reviews individual nutrient requirements but has not undertaken a comprehensive review of the minimum and maximum levels for certain nutrients since 1998. FDA now seeks public…

Read More